IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices

Abstract Patients undergoing heart transplantation (HTx) with active infection of left ventricular assist devices (LVAD) are at high risk for postoperative infections. Between 2021 and 2022, five (P1–P5) of a total of n = 44 patients underwent HTx in our department while suffering from LVAD infectio...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Moritz Benjamin Immohr, Charlotte Böttger, Hug Aubin, Ralf Westenfeld, Daniel Oehler, Raphael Romano Bruno, Hannan Dalyanoglu, Igor Tudorache, Payam Akhyari, Artur Lichtenberg, Udo Boeken
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Oxford University Press 2022-10-01
Saila:	ESC Heart Failure
Gaiak:	IGM‐IVIG Driveline infection Heart transplantation Infection Left ventricular assist device Immunoglobulin
Sarrera elektronikoa:	https://doi.org/10.1002/ehf2.14074
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!